CD4 and asthma: Although hyperactive ASM and BEC in the mucosal epithelium are unquestionably a significant component of asthma pathophysiology, it remains unclear as to whether abnormal ORMDL3 expression in these tissues exacerbates disease, or whether the association of elevated ORMDL3 with asthma might be mediated primarily in immune cells like CD4+ T cells.